Myriad Genetics Marking Prostate Cancer Awareness Month with Hereditary Testing Outreach

Myriad Genetics Marking Prostate Cancer Awareness Month with Hereditary Testing Outreach
Myriad Genetics is marking Prostate Cancer Awareness Month by highlighting the importance of assessing the hereditary risk of the disease. The company is using its myRisk Hereditary Cancer test in its public outreach effort in September. The tool identifies mutations in men diagnosed with prostate cancer. Myriad develops and commercializes molecular diagnostic tests that can determine the risk of

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *